EIX
47
-11
EXR
37
15
SLB
37
-4
NEM
53
5
NRG
35
3
PFG
36
3
TGT
54
-3
KMX
47
7
JNJ
33
-12
BSX
73
4
CPB
22
-3
FTI
81
3
GOOGL
54
-4
BMY
43
-3
PLD
33
-4
MHK
33
3
PHM
43
6
TRV
42
2
VTR
35
4
NAVI
35
-5
EIX
47
-11
EXR
37
15
SLB
37
-4
NEM
53
5
NRG
35
3
PFG
36
3
TGT
54
-3
KMX
47
7
JNJ
33
-12
BSX
73
4
CPB
22
-3
FTI
81
3
GOOGL
54
-4
BMY
43
-3
PLD
33
-4
MHK
33
3
PHM
43
6
TRV
42
2
VTR
35
4
NAVI
35
-5
Financhill
Back

Anheuser-Busch InBev SA/NV Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
15

BUD
Anheuser-Busch InBev SA/NV

Last Price:
$46.16
Seasonality Move:
1.64%
Sell
8

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-9.08%
Sell
15
Anheuser-Busch InBev SA/NV (BUD) is a Sell

Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?

  • The current Anheuser-Busch InBev SA/NV [BUD] share price is $49.03. The Score for BUD is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • BUD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
8
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BUD Stock Price Chart

What is Anheuser-Busch InBev SA/NV's stock price today?

  • The Anheuser-Busch InBev SA/NV share price today is $49.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BUD is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $48.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

BUD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.52 Sell
Relative Strength Index (14 RSI): 25.2 Sell
Chaikin Money Flow: 1649570 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.59 - 52.87) Sell
Bollinger Bands (100): (53.36 - 64.58) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: -235099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.1 - 56.94) Sell
Bollinger Bands (100): (51.5 - 57.46) Sell

BUD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.55 Sell
20-day SMA: 50.73 Sell
50-day SMA: 54.2 Sell
200-day SMA: 59.96 Sell
8-day EMA: 49.53 Sell
20-day EMA: 50.75 Sell
50-day EMA: 53.89 Sell
200-day EMA: 58.72 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.85 Sell
20-day SMA: 53.18 Sell
50-day SMA: 55.63 Sell
200-day SMA: 51.03 Sell
8-day EMA: 50.82 Sell
20-day EMA: 52.67 Sell
50-day EMA: 54.22 Sell
200-day EMA: 49.96 Sell

Anheuser-Busch InBev SA/NV Earnings Growth & BUD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.44 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

Anheuser-Busch InBev SA/NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):